News & Media

Find links to news and information about Cala Health, our history, and Cala Trio in our newsroom.

In The News

Cala Cites Positive Data in Trio Tremor Trial

Cala Cites Positive Data in Trio Tremor Trial

Bioelectronic company Cala Health released positive data from its ongoing PROSPECT trial demonstrating that a majority of patients using its FDA-cleared Cala Trio device reported a reduction in hand tremors.

Cala Health aims to restore functionality to essential tremor patients with wearables

Cala Health aims to restore functionality to essential tremor patients with wearables

For Kate Rosenbluth, founder and chief scientific officer of Cala Health, and Renee Ryan, its CEO, the painting is a reminder of why they do their work every day: to restore functionality — and even bring back the joy of life — for the estimated 7 million people in the U.S. living with the condition.

Current Therapy Cala Health Takes on Neurological conditions with a novel approach- by reverse engineering the body's nervous system.

Current Therapy Cala Health Takes on Neurological conditions with a novel approach- by reverse engineering the body's nervous system.

I sat in an occupational therapy office with electrodes stuck to my right hand, playing a game of Connect Four. Or at least I attempted to play, unsuccessfully, as I had for the last 10 weeks.

Cala Health: Medtech as Bioelectric Medicine

Cala Health: Medtech as Bioelectric Medicine

Wearables are a hot topic in medtech circles today. But are they really medtech? Cala Health’s Trio device for treating essential tremors underscores the challenges and opportunities that wearables represent when compared to traditional medical devices.

It looks like a smartwatch, but this new device is helping people with tremors

It looks like a smartwatch, but this new device is helping people with tremors

People who live with tremors know it can impact every part of your life. Essential tremor is a nervous system disorder that causes involuntary shaking. It can be hard to write legibly, and even eat or drink without spilling.

Individualized, Non-invasive therapy for essential tremor- An interview with Kate Rosenbluth of Cala Health

Individualized, Non-invasive therapy for essential tremor- An interview with Kate Rosenbluth of Cala Health

When I was an Innovation Fellow, doing needs finding with my team, I met a man whose hands shook so badly that he could no longer write a letter to his wife or drink a coffee with a friend. He had a severe form of a debilitating disorder called essential tremor.

Watch Like Device Helps Tremors

Watch Like Device Helps Tremors

Doctors from the University of Arkansas for Medical Sciences in Little Rock are looking into new ways to reduce and hopefully stop essential tremors for patients.

Treatment With Neuromodulation Device Improves Essential Tremor in Clinical Trial

Treatment With Neuromodulation Device Improves Essential Tremor in Clinical Trial

In the PROSPECT study, a wrist-worn neuromodulation device Cala Trio by CalaHealth, Inc. provided symptomatic relief for essential tremor (ET).

Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial Reports

Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial Reports

Using Cala Health’s non-invasive therapeutic device Cala Trio for 40 minutes twice daily effectively helped to reduce hand tremors within three months, results from a clinical study show.

Record Clinical Trial Enrollment Made Possible by IETF and Their Members

Record Clinical Trial Enrollment Made Possible by IETF and Their Members

Patient recruitment is usually the biggest challenge in conducting clinical trials. Thanks to the International Essential Tremor Foundation and their members, CalaHealth recently enrolled the largest therapeutic essential tremor study in record time.

Essential Tremor Symptoms, Severity Improved With Cala Trio Neuromodulation Device

Essential Tremor Symptoms, Severity Improved With Cala Trio Neuromodulation Device

Results of the landmark PROSPECT trial of the Cala Trio, a wrist-worn wearable neuromodulation device for essential tremor (ET), suggest that the device is safe and effective for the reduction of hand tremor in individuals with ET.

Six New HealthTech Founders Join the StartUp Health Platform

Six New HealthTech Founders Join the StartUp Health Platform

StartUp Health has been the most active investor in health innovation companies in 2019. And we’re not slowing down. Meet the latest Health Transformers to join our family.

Media

Electricity as Medicine: Lux Capital's Josh Wolfe and Cala Health CEO Renee Ryan

Electricity as Medicine: Lux Capital's Josh Wolfe and Cala Health CEO Renee Ryan

Lux Capital Managing Partner and Co-Founder Josh Wolfe visits the headquarters of Lux portfolio company Cala Health in Burlingame, California and has a conversation with CEO Renee Ryan. You’ll get an inside look at how Cala is empowering people with chronic disease.

Treating Essential Tremors with Bioelectronic Wearable Device with Renee Ryan Cala Health

Treating Essential Tremors with Bioelectronic Wearable Device with Renee Ryan Cala Health

Cala Health CEO talks about the focus of Cala on using electricity as medicine by developing wearable electronics to treat tremors in the hands of essential tremor patients.

CEO, Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

CEO, Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

In this episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.

Recognition

Cala Health Named One of 15 Most Promising Private Digital Health Companies

Cala Health Named One of 15 Most Promising Private Digital Health Companies

Digital Health 150 is CB Insights' annual ranking of the 150 most promising digital health startups in the world.

Cala Health named A GOLD WINNER of the 2020 Edison Awards

Cala Health named A GOLD WINNER of the 2020 Edison Awards

Cala Trio therapy took the GOLD award for Diagnostics & Disease Treatment in the Medical Device/Dental category. Among the nomination entries comprising the best products, services, and businesses in innovation for the year 2020, Cala Trio was chosen as a winner by a panel of over 3,000 leading business executives from around the world.

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™

Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn device.

Game Changing Startups 2020

Game Changing Startups 2020

We highlight 2020’s emerging trends to watch and high-momentum startups with world-changing potential. The past few decades have seen unprecedented levels of innovation, especially in what Peter Thiel calls the world of “bits,” or software, internet, and mobile technology.

Press Releases

Cala Health Receives FDA Breakthrough Device Designation for Cala Trio™ Therapy to Treat Action Tremors in Parkinson's Disease

October 22, 2020

First Real-World Evidence Demonstrates Cala Trio's Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation

September 14, 2020

Cala Health Announces Continued Growth and Momentum with Clinical, Product Development, and Management Milestones to Support Cala Trio Therapy for the Treatment of Essential Tremor

August 17, 2020

Cala Health Announces Positive Topline Data from Landmark PROSPECT Study for Essential Tremor (ET)

September 22, 2019

Cala Health Names Veteran Leader Renee Ryan as Chief Executive Officer

September 3, 2019

Researcher Developing Nerve Stimulation Device

June 12, 2019

Cala Health Raises $50 Million Series C Funding

May 20, 2019

Cala Health Licenses Innovative Technology from Partners Healthcare to Develop and Deliver Novel Therapies for Patients with Chronic Disease

March 11, 2019

Cala Health participates in Industry and Academic Forum resulting in the Initial Guiding Principles on Ethics in Digital Health

February 20, 2019

Cala Health Enrolls First Patients in Landmark PROSPECT Study for Essential Tremor

December 16, 2018

Cala Health Receives FDA Clearance for Cala ONE, A Neuroperipheral Therapy for Essential Tremor

April 25, 2018

American Academy of Neurology 2018 Emerging Science Program: Non-Invasive Peripheral Nerve Stimulation for Symptomatic Relief of Hand Tremor in Essential Tremor

April 18, 2018

Noninvasive Neuromodulation in Essential Tremor Demonstrates Relief in a Sham-Controlled Pilot Trial

April 16, 2018

Exponential Medicine 2017: Delivering Electricity as Medicine

November 7, 2017

Cala Health's CEO Kate Rosenbluth selected as a Hive Innovator for 2017 by TEDMED

November 1, 2017